Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03151811
Title A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide (OCEAN)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Oncopeptides AB

multiple myeloma


Dexamethasone + Pomalidomide

Dexamethasone + Melflufen

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | BEL | AUT

No variant requirements are available.